ASSERTIO HOLDINGS INC (ASRT)
US04546C2052 - Common Stock
ASSERTIO HOLDINGS INC
NASDAQ:ASRT (4/24/2024, 7:00:01 PM)
After market: 0.87 +0 (+0.51%)0.8656
-0.04 (-4.83%)
Company Profile
Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. The company is headquartered in Lake Forest, Illinois and currently employs 30 full-time employees. Its commercial portfolio of branded products focuses on three areas: neurology, rheumatology, and pain and inflammation. Its primary marketed products include INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Otrexup (methotrexate) injection for subcutaneous use, Sympazan (clobazam) oral film, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipso (diclofenac potassium) Liquid filled capsules. The company also offers OXAYDO (oxycodone HCI, USP) tablets. INDOCIN (indomethacin) Suppositories are nonsteroidal anti-inflammatory drug (NSAID), indicated for moderate to severe rheumatoid arthritis, including acute flares of chronic diseases, moderate to severe ankylosing spondylitis and others. Its portfolio also includes ROLVEDON (eflapegrastim-xnst) Injection asset.
Company Info
ASSERTIO HOLDINGS INC
100 S. Saunders Road, Suite 300
Lake Forest ILLINOIS 60045
P: 12244197106
CEO: Daniel A. Peisert
Employees: 30
Website: https://www.assertiotx.com/
ASRT News
LAKE FOREST, Ill., April 01, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with...
a month ago - Bragar Eagel & SquireASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmFourth Quarter Net Product Sales $32.5 Million, Cash Flow from Operations of $5.7 Million 2024 Full Year Outlook for Net...
2 months ago - The Law Offices of Frank R. CruzThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Assertio Holdings, Inc. (ASRT)
2 months ago - Berger MontagueCLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Assertio Holdings, Inc. (NASDAQ: ASRT) Investors to Inquire About a Securities Fraud Class Action by March 5, 2024/PRNewswire/ -- Nationally recognized law firm, Berger Montague PC, informs investors that a lawsuit was filed against Assertio Holdings, Inc. ("Assertio")...
2 months ago - Berger MontagueDEADLINE TOMORROW: Berger Montague Advises Assertio Holdings (NASDAQ: ASRT) Investors to Inquire About a Securities Fraud Class Action by March 5, 2024ASRT Twits
Here you can normally see the latest stock twits on ASRT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
